Richard J H Smith Selected Research

Antineutrophil Cytoplasmic Antibodies (ANCA)

5/2016	Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.
7/2012	Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard J H Smith Research Topics

Disease

46	Hearing Loss (Hearing Impairment) 12/2023 - 05/2002
25	Deafness (Deaf Mutism) 06/2023 - 05/2002
20	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2024 - 09/2007
18	Atypical Hemolytic Uremic Syndrome 11/2023 - 02/2009
17	Glomerulonephritis 10/2022 - 05/2010
16	Nonsyndromic Deafness 05/2020 - 05/2002
8	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 02/2011
8	Otosclerosis 05/2012 - 09/2007
7	Proteinuria 01/2024 - 09/2007
6	Recurrent respiratory papillomatosis 03/2022 - 11/2002
5	Paraproteinemias (Monoclonal Gammopathy) 01/2024 - 09/2013
5	Inflammation (Inflammations) 10/2022 - 06/2008
5	Rare Diseases (Rare Disease) 10/2022 - 09/2007
4	Kidney Diseases (Kidney Disease) 01/2024 - 12/2017
4	Renal Insufficiency (Renal Failure) 10/2022 - 05/2005
4	Sensorineural Hearing Loss 01/2022 - 12/2010
3	Disease Progression 02/2024 - 09/2005
3	Pendred syndrome 01/2023 - 02/2002
3	Monoclonal Gammopathy of Undetermined Significance 10/2022 - 11/2010
3	Infections 01/2022 - 06/2016
3	Thrombocytopenia (Thrombopenia) 11/2020 - 02/2011
3	Autosomal Dominant 5 Deafness 05/2020 - 08/2005
3	Thrombotic Microangiopathies 01/2020 - 01/2014
3	Male Infertility (Male Sterility) 01/2018 - 04/2009
3	24 Autosomal Recessive Deafness 03/2010 - 05/2007
2	Hemolysis 01/2023 - 01/2019
2	Pierre Robin Syndrome (Syndrome, Pierre Robin) 01/2021 - 03/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 09/2013
2	Auditory neuropathy 08/2015 - 01/2008
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2014 - 08/2011
2	Pathologic Constriction (Stenosis) 05/2011 - 04/2004
2	Usher Syndromes (Usher Syndrome) 08/2010 - 06/2009
2	Papilloma (Papillomatosis) 04/2010 - 11/2002
2	Branchio-Oto-Renal Syndrome (Branchio Oculo Facial Syndrome) 04/2007 - 09/2004
2	Carcinogenesis 01/2006 - 11/2005
1	Persistent Infection 01/2024
1	Myasthenia Gravis 01/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Neuromyelitis Optica (Devic's Disease) 01/2023
1	Complement Factor I Deficiency 12/2022
1	Atrophy 10/2022
1	Fibrosis (Cirrhosis) 10/2022
1	Asthma (Bronchial Asthma) 03/2022
1	Respiratory Insufficiency (Respiratory Failure) 03/2022

Drug/Important Bio-Agent (IBA)

37	Complement System Proteins (Complement)IBA 02/2024 - 10/2004
17	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2002
14	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
13	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 08/2003
8	Connexin 26IBA 08/2012 - 08/2002
6	Antigen-Antibody Complex (Immune Complex)IBA 01/2024 - 05/2009
6	Complement Factor H (Factor H)IBA 09/2021 - 05/2005
6	Capsules (Microcapsules)IBA 05/2012 - 09/2007
5	CreatinineIBA 01/2024 - 04/2016
5	Complement Factor B (Factor B)IBA 11/2020 - 05/2010
4	NucleotidesIBA 12/2016 - 11/2005
4	Immunoglobulins (Immunoglobulin)IBA 06/2016 - 05/2009
3	Biomarkers (Surrogate Marker)IBA 02/2024 - 06/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2003
3	Complement C3 (C3 Complement)IBA 01/2021 - 04/2015
3	MicroRNAs (MicroRNA)IBA 01/2019 - 03/2010
3	Mitochondrial DNA (mtDNA)IBA 05/2015 - 01/2006
3	ConnexinsIBA 07/2011 - 12/2003
3	Nonsense Codon (Nonsense Mutation)IBA 02/2011 - 02/2007
3	cyclonite (RDX)IBA 03/2010 - 05/2007
2	ProteomeIBA 06/2023 - 02/2023
2	eculizumab FDA Link 01/2023 - 09/2007
2	Serine Proteases (Serine Protease)IBA 12/2022 - 01/2008
2	chemotactic factor inactivatorIBA 12/2022 - 11/2012
2	Complement Factor I (C3b Inactivator)IBA 12/2022 - 11/2012
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 10/2022 - 06/2015
2	AminoglycosidesIBA 01/2022 - 06/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2016 - 07/2012
2	Rituximab (Mabthera)FDA Link 09/2013 - 09/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2013 - 12/2010
2	Cidofovir (Vistide)FDA Link 04/2010 - 11/2005
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 09/2009 - 08/2009
2	Fibrinogen (Factor I)FDA Link 02/2009 - 02/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2008 - 09/2007
2	CytosineIBA 01/2007 - 11/2005
2	Messenger RNA (mRNA)IBA 01/2007 - 11/2002
2	Myosins (Myosin)IBA 11/2005 - 05/2002
1	AutoantibodiesIBA 02/2024
1	ReninIBA 11/2023
1	Aquaporin 4IBA 01/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	Complement C3 Nephritic FactorIBA 10/2022
1	pembrolizumabIBA 03/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022
1	16S Ribosomal RNAIBA 01/2022
1	Immunoglobulin G (IgG)IBA 09/2021
1	Bevacizumab (Avastin)FDA Link 01/2021

Therapy/Procedure

16	Therapeutics 12/2023 - 10/2002
8	Cochlear Implantation 01/2022 - 02/2002
6	Cochlear Implants (Cochlear Implant) 01/2022 - 05/2002
3	Transplantation 01/2022 - 02/2009
2	Otoscopes 11/2020 - 05/2020
2	Lasers (Laser) 01/2017 - 05/2011
1	Organ Transplantation 10/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Distraction Osteogenesis 01/2021